Genetic mutation raises CRC mortality risk, studies show

11/14/2012 | Healio

Having the genetic BRAF mutation doubles the mortality risk for colorectal cancer patients, according to an analysis of 26 CRC studies. Canadian researchers said the data show that if the BRAF mutation can successfully be inhibited it could improve survival for patients.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC